[HTML][HTML] Atherosclerosis, cardiovascular disease, and COVID-19: a narrative review

C Vilaplana-Carnerero, M Giner-Soriano, À Dominguez… - Biomedicines, 2023 - mdpi.com
Atherosclerosis is a chronic inflammatory and degenerative process that mainly occurs in
large-and medium-sized arteries and is morphologically characterized by asymmetric focal …

[HTML][HTML] SARS-CoV-2 and atherosclerosis: should COVID-19 be recognized as a new predisposing cardiovascular risk factor?

M Vinciguerra, S Romiti, GM Sangiorgi, D Rose… - Journal of …, 2021 - mdpi.com
At the beginning of the COVID-19 pandemic, the lung was recognized as the main target
organ; now, new evidence suggests that SARS-CoV-2 infection leads to vascular disease. In …

[HTML][HTML] Impact of COVID-19 on cardiovascular disease

I Vosko, A Zirlik, H Bugger - Viruses, 2023 - mdpi.com
Coronavirus disease 2019 (COVID-19) is a viral infection with the novel severe acute
respiratory distress syndrome corona virus 2 (SARS-CoV-2). Until now, more than 670 …

[HTML][HTML] Possible correlations between atherosclerosis, acute coronary syndromes and COVID-19

O Grzegorowska, J Lorkowski - Journal of Clinical Medicine, 2020 - mdpi.com
An outbreak of SARS-CoV-2 infection in December 2019 became a major global concern in
2020. Since then, several articles analyzing the course, complications and mechanisms of …

The COVID-19 pandemic and coronary heart disease: the next surge

A Shaikh, SD Khan, F Baloch, SS Virani… - Current Atherosclerosis …, 2023 - Springer
Abstract Purpose of Review In this narrative review, we highlight different ways in which the
COVID-19 pandemic has impacted coronary heart disease (CHD) burden and how a surge …

[HTML][HTML] COVID-19 and coronary heart disease

A Naz, M Billah - Encyclopedia, 2021 - mdpi.com
Definition Coronary heart disease (CHD) is the leading cause of mortality worldwide. One of
the main contributions of mortality and morbidity in CHD patients is acute myocardial …

[HTML][HTML] COVID-19 and cardiovascular disease: from basic mechanisms to clinical perspectives

M Nishiga, DW Wang, Y Han, DB Lewis… - Nature Reviews …, 2020 - nature.com
Abstract Coronavirus disease 2019 (COVID-19), caused by a strain of coronavirus known as
severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has become a global …

[HTML][HTML] Pathomechanisms of SARS-CoV-2 infection and development of atherosclerosis in patients with COVID-19: A review

AZ Gospodarczyk, C Wojciechowska, KP Marczewski… - Medicine, 2022 - journals.lww.com
The pandemic of coronavirus disease 2019 (COVID-19) has posed a major health challenge
for over 2 years. The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) that …

[HTML][HTML] Effect of coronary artery disease on COVID-19—prognosis and risk assessment: a systematic review and meta-analysis

L Szarpak, M Mierzejewska, J Jurek, A Kochanowska… - Biology, 2022 - mdpi.com
Simple Summary As of October 2021, over 245 million people have been infected and
nearly 5 million have died due to COVID-19. Atherosclerosis is a lipid-driven chronic …

[HTML][HTML] Impact of cardiovascular diseases on COVID-19: A systematic review

Q Cao, HY Lei, ML Yang, L Wei, YM Dong… - … medical journal of …, 2021 - ncbi.nlm.nih.gov
In December 2019, pneumonia of unknown cause broke out, and currently more than 150
countries around the world have been affected. Globally, as of 5: 46 pm CET, 6 November …